v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 211,822 $ 222,503
Short-term investments 65,852 57,812
Accounts receivable 95,852 78,286
Inventory 22,418 22,403
Prepaid expenses and other current assets 14,874 11,784
Total current assets 410,818 392,788
Restricted cash 425 425
Long-term investments 20,912 12,526
Property and equipment, net 1,108 1,139
Operating lease right-of-use assets 7,663 8,675
Intangible assets, net 243,845 249,819
Other assets 5,474 5,382
Total assets 690,245 670,754
Current liabilities:    
Accounts payable 11,639 14,618
Accrued expenses and other current liabilities 115,938 111,933
Total current liabilities 127,577 126,551
Operating lease liabilities, noncurrent 7,003 7,972
Convertible notes payable, net, noncurrent 308,509 308,082
Other liabilities 13,900 2,509
Total liabilities 456,989 445,114
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of March 31, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value; 200,000,000 shares authorized; 49,451,223 and 48,338,096 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 5 5
Additional paid-in capital 892,367 870,189
Accumulated deficit (658,858) (644,181)
Accumulated other comprehensive loss (258) (373)
Total stockholders’ equity 233,256 225,640
Total liabilities and stockholders’ equity $ 690,245 $ 670,754